Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder nodule successfully treated with laser Co2 ablation: a case report and literature review
Accepted: 10 December 2023
HTML: 3
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
This case report describes an 83-year-old patient with a history of non-melanoma skin cancer who presented with a violaceous, painless nodule on the neck. Dermoscopic examination and subsequent biopsy revealed a Small/Medium CD4+ T-cell lymphoproliferative disorder (SMPLPD) of the skin. Although excision was initially recommended, the patient opted for treatment with CO2 laser ablation. The procedure had some minor complications but resulted in successful healing. SMPLPDs are a rare skin condition with limited treatment data, and this case suggests that CO2 laser ablation with minimal margins could be a viable alternative for selected patients, reducing bleeding and promoting second-intention healing for small nodules. However, more extensive follow-up data for SMPLPD cases are needed to understand long-term outcomes better.
Ungureanu L, Vasilovici A, Șenilă SC, et al. Dermoscopy in the diagnosis of cutaneous lymphoma (Review). Exp Ther Med 2022;23:377.
Grogg KL, Jung S, Erickson LA, et al. Primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma: a clonal T-cell lymphoproliferative disorder with indolent behavior. Mod Pathol 2008;21:708–15.
Bakr F, Wain EM, Barlow R, Robson A. Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder or Primary Cutaneous Marginal Zone B-Cell Lymphoma? Two Distinct Entities With Overlapping Histopathological Features. Am J Dermatopathol 2021;43:e204–12.
Plumptre IR, Said JT, Sun T, et al. Clinical features and treatment outcomes for primary cutaneous CD4+ small/medium Tcell lymphoproliferative disorder: a retrospective cohort study from the Dana-Farber Cancer Institute and updated literature review. Leuk Lymphoma 2022;63:2832–46.
Bakr F, Wain EM, Wong S, et al. Prominent Blasts in Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder. A Reconsideration of Diagnostic Criteria. Am J Dermatopathol 2021;43:e190–6.
Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016;127:2375–90.
Alberti Violetti S, Alaibac M, Ardigò M, et al. An expert consensus report on mycosis fungoides in Italy: epidemiological impact and diagnostic-therapeutic pathway. Ital J Dermatol Venerol 2021;156:413–21.
Pileri A, Morsia E, Zengarini C, et al. Epidemiology of cutaneous T-cell lymphomas: state of the art and a focus on the Italian Marche region. Eur J Dermatol 2023;33:360–7.
Ayala D, Ramón MD, Cabezas M, Jordá E. Primary Cutaneous CD4+ Small/Medium-Sized Pleomorphic T-Cell Lymphoma With Expression of Follicular T-Helper Cell Markers and Spontaneous Remission. Actas Dermosifiliogr 2016;107:357–9.
Yi LG, Gru AA. Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder Mimicking Jessner Lymphocytic Infiltrate and Tumid Lupus- A Report of Two Cases. Am J Dermatopathol 2021;43:e293–7.
Salah E. Primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoproliferative disorder: Where do we stand? A systematic review. JDDG: J Dtsch Dermatol Ges 2019;17:123–36.
Gru AA, Wick MR, Eid M. Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder- clinical and histopathologic features, differential diagnosis, and treatment. Semin Cutan Med Surg 2018;37:39–48.
Kim J, Jeong M, Jun D, et al. Primary cutaneous CD4+ small/medium T-cell lymphoma: a case report. Arch Craniofac Surg. 2021;22:199–203.
Kim EJ, Aria AB, Wilmas K, et al. Primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoproliferative disorder in a pediatric patient successfully treated with low-dose radiation. Pediatr Dermatol 2019;36:e23–6.
Valentim F de O, Oliveira CC, Miot HA. Case for diagnosis. Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder. An Bras Dermatol 2019;94:99–101.
Copyright (c) 2024 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.